Trian In DuPont Move

Aug 16 2013 | 1:18am ET

Activist hedge fund Trian Fund Management has amassed a huge stake in chemical giant DuPont Co. and has already begun pushing for changes.

Trian, led by Nelson Peltz, has bought a 2.2% stake in DuPont worth $1.3 billion. And Peltz has wasted no time, having already met with DuPont CEO Ellen Kullman and other senior executives.

According to the Wilmington News-Journal, Peltz presented DuPont with one of his famous white papers, suggesting how to boost shareholder value and improve long-term growth prospects.

"We will evaluate any ideas Trian may have in the context of our ongoing initiatives to build a higher value, higher growth company for our shareholders," DuPont spokesman Michael Hanretta said.

DuPont this week adopted several poison pills, including provisions that would pay executives larger severance and changing the way that board candidates are nominated.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR